Popular Categories
FDA Extends Expiration Dates of Certain Lots of State and Local Held Doxycycline
The Food and Drug Administration (FDA) has recently released a memo indicating that six lots of Doxycycline Hyclate 100-mg tablets...
Jun 03, 2016 | Raymond Puerini
Draft Emergency Use Authorization Guidance Available for Public Health Stakeholder...
The Food and Drug Administration (FDA) recently published updated draft guidance entitled ‘‘Emergency Use Authorization of Medical...
May 04, 2016 | Raymond Puerini
Capturing Patient and Vaccine Information at Mass Vaccination Clinics – A Catalog of...
By Tom Fitzgerald, MPH; Pandemic Influenza Vaccine Response Fellow, CDC/NCIRD/ISD For many health departments, data collection during...
Feb 18, 2016 | Mary Hodges
Gaps Remain for Pediatric Medical Countermeasures
During public health emergencies, children are a particularly vulnerable population as they have unique physical, physiological, and...
Jan 26, 2016 | Raymond Puerini
New Anthrax Clinical Guidance Released
On Friday, December 4, 2015, CDC released the Morbidity and Mortality Weekly Report (MMWR) with new clinical guidance for the use of...
Dec 07, 2015 | Raymond Puerini
HHS to Obtain Two Inhalational Anthrax Treatments for National Supply
In order to better protect the American people, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary...
Nov 20, 2015 | Mary Hodges
CDC Releases the BP4 MCM ORR Portfolio and Implementation Fact Sheet
On Friday, October 23, the CDC released the Budget Period 4 (BP4) Medical Countermeasure Operational Readiness Review (MCM ORR)...
Oct 26, 2015 | Raymond Puerini
Call for Presenters: CDC Second Wednesday Webinars
The CDC Division of State and Local Readiness (DSLR) is currently looking for state and local health department presenters for an...
Oct 13, 2015 | Raymond Puerini
Incorporating At-Risk Populations into Medical Countermeasure Planning
Defining “At-Risk” Populations When asked to define which population groups are included under the “at-risk population”...
Sep 15, 2015 | Raymond Puerini
FDA Extends Expiration Dates of Certain Lots of State and Local Held DoxycyclineThe Food and Drug Administration (FDA) has recently released a memo indicating that six lots of Doxycycline Hyclate 100-mg tablets manufactured by West-Ward Pharmaceuticals may be used beyond their labeled expiration dates assuming they were stored under the manufacturer’s labeled storage conditions. FDA is not requiring that these products be relabeled but stakeholders who dispense these... Jun 03, 2016 | Raymond Puerini |
Draft Emergency Use Authorization Guidance Available for Public Health Stakeholder CommentThe Food and Drug Administration (FDA) recently published updated draft guidance entitled ‘‘Emergency Use Authorization of Medical Products and Related Authorities’’ for public health stakeholder and industry comment. This is an update to the July 2007 Emergency Use Authorization (EUA) guidance to reflect Pandemic and All-Hazards Preparedness Re-authorization Act (PAHPRA) amendments to the EUA... May 04, 2016 | Raymond Puerini |
Capturing Patient and Vaccine Information at Mass Vaccination Clinics – A Catalog of Electronic TechnologiesBy Tom Fitzgerald, MPH; Pandemic Influenza Vaccine Response Fellow, CDC/NCIRD/ISD For many health departments, data collection during mass vaccination clinics conducted in response to a pandemic or outbreak is often done manually. This can be time-consuming and labor intensive, but it is an extremely important component of pandemic vaccine response, particularly if there are multiple […] Feb 18, 2016 | Mary Hodges |
Gaps Remain for Pediatric Medical CountermeasuresDuring public health emergencies, children are a particularly vulnerable population as they have unique physical, physiological, and psychological characteristics that vary from adults. Additionally, the medical products and formulations children need often differ from adults and some medical products may not have the same usage approvals for children as they do for adults. Earlier this month... Jan 26, 2016 | Raymond Puerini |
New Anthrax Clinical Guidance ReleasedOn Friday, December 4, 2015, CDC released the Morbidity and Mortality Weekly Report (MMWR) with new clinical guidance for the use of Medical Countermeasures (MCMs) during an Anthrax mass-casualty event. Guidance Abstract Snippet: “This report addresses elements of hospital-based acute care, specifically antitoxins and intravenous antimicrobial use, and the diagnosis and management of common... Dec 07, 2015 | Raymond Puerini |
HHS to Obtain Two Inhalational Anthrax Treatments for National SupplyIn order to better protect the American people, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) will add two types of anthrax antitoxin drugs for the Strategic National Stockpile (SNS) as options to treat inhalational anthrax. The Secretary of Homeland Security determined anthrax to be a material […] Nov 20, 2015 | Mary Hodges |
CDC Releases the BP4 MCM ORR Portfolio and Implementation Fact SheetOn Friday, October 23, the CDC released the Budget Period 4 (BP4) Medical Countermeasure Operational Readiness Review (MCM ORR) Portfolio and the BP4 Implementation Fact Sheet. The MCM ORR Portfolio includes the following documents*: BP4 Reference Guide MCM ORR PDF fillable tool MCM ORR Guidance Jurisdictional Data Sheet (JDS) MCM ORR Preparation Guide MCM ORR […] Oct 26, 2015 | Raymond Puerini |
Call for Presenters: CDC Second Wednesday WebinarsThe CDC Division of State and Local Readiness (DSLR) is currently looking for state and local health department presenters for an upcoming Second Wednesday Webinar in the month of December. Presenters are needed to discuss promising practices for the following topic: Full-Scale Exercise Planning: CDC is looking for State and Local Health Departments to share […] Oct 13, 2015 | Raymond Puerini |
Incorporating At-Risk Populations into Medical Countermeasure PlanningDefining “At-Risk” Populations When asked to define which population groups are included under the “at-risk population” umbrella in a jurisdiction, the answers could vary greatly from person to person. There are a wide variety of public health preparedness planning considerations that need to be met to ensure specific at-risk groups get access to emergency information and […] Sep 15, 2015 | Raymond Puerini |
Subscribe Today
Sign Up for the E-mail Digests
Create an account or login to MyNACCHO and go to "My Subscriptions."
SUBSCRIBE NOW
